催眠药对阻塞性睡眠呼吸暂停严重程度及内型的影响:系统综述与荟萃分析
该系统综述与荟萃分析纳入27项随机临床试验,评估口服催眠药对唤醒阈值、OSA严重程度及颏舌肌反应性的影响。结果显示催眠药仅轻度提高唤醒阈值(2.7 cm H2O),未改变OSA严重程度(AHI变化-1.4 events/h),且对颏舌肌反应性无影响。个体患者数据荟萃分析(N=114)未发现唤醒阈值变化与AHI的关联,仅极低唤醒阈值者AHI降低约10%。结论不推荐催眠药作为OSA替代治疗,除非合并失眠或作为极低唤醒阈值患者的联合治疗。
要点
- 催眠药仅轻度提高唤醒阈值,未显著改善OSA严重程度。
- 催眠药对颏舌肌反应性无影响,证据质量高。
- 不推荐催眠药作为OSA替代治疗,除非合并失眠或极低唤醒阈值者联合治疗。
核心结论
- 催眠药不能作为OSA的替代治疗,除非患者合并失眠或作为极低唤醒阈值个体的联合治疗。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、CENTRAL和ClinicalTrials.gov的随机临床试验,共纳入27项研究(25项用于AHI,11项用于唤醒阈值,4项用于颏舌肌反应性)。
- 采用GRADE评估证据质量,并利用个体患者数据荟萃分析(N=114)探索治疗后AHI与唤醒阈值百分比降低的关联。
主要发现
- 催眠药轻度提高唤醒阈值(均差2.7 cm H2O会厌压力摆动,95%CI 1.5至3.8;中等证据质量)。
- 催眠药未改变OSA严重程度(AHI变化-1.4 events/h,95%CI -3.5至0.7;中等证据质量)。
- 个体患者数据荟萃分析(N=114)显示唤醒阈值变化与AHI无关联,独立于唤醒阈值亚组。
- 极低唤醒阈值或唤醒阈值较安慰剂增加0-25%的个体,治疗后AHI降低幅度最大但仍有限(约10%)。
- 催眠药对颏舌肌反应性无影响(高证据质量)。
关键数值与推荐
- 唤醒阈值变化:均差2.7 cm H2O(95%CI 1.5至3.8),中等证据质量。
- AHI变化:均差-1.4 events/h(95%CI -3.5至0.7),中等证据质量。
- 极低唤醒阈值或唤醒阈值增加0-25%者AHI降低约10%。
临床怎么用
- 不鼓励临床使用催眠药作为OSA的替代治疗,除非患者合并失眠或作为极低唤醒阈值个体的联合治疗。
- 对于极低唤醒阈值患者,催眠药可能带来有限的AHI降低(约10%),但需个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Low arousal threshold and poor muscle responsiveness are common determinants of obstructive sleep apnea (OSA). Hypnotics were hypothesized as an alternative OSA treatment via raising the arousal threshold and possibly genioglossus responsiveness. Objectives: To examine the effect of common hypnotics on arousal threshold, OSA severity, and genioglossus responsiveness. Methods: We searched MEDLINE, Embase, CENTRAL, and ClinicalTrials.gov for randomized clinical trials, and we ran meta-analyses to determine the effect of oral hypnotics on arousal threshold, OSA severity, and genioglossus responsiveness. The Grades of Recommendation Assessment, Development and Evaluation was used to rate the quality of evidence (QoE). The association between post-treatment apnea-hypopnea index (AHI) and arousal threshold percentage reductions was explored in individual patient data meta-analyses (overall sample and low arousal threshold subgroups). Measurements and Main Results: On the basis of our analysis (27 studies; 25 for AHI, 11 for arousal threshold, 4 for genioglossus responsiveness), hypnotics minimally raised arousal threshold (mean difference [95% confidence interval], 2.7 [1.5, 3.8] cm H2O epiglottic pressure swings; moderate QoE) but did not change OSA severity (-1.4 [-3.5, 0.7] events/h; moderate QoE). Individual patient data meta-analysis (N = 114) showed no association between changes in arousal threshold and AHI, independent of arousal threshold subgrouping. However, people with very low arousal threshold or those who exhibited a 0-25% arousal threshold increase from placebo experienced the greatest, yet still modest, post-treatment AHI reductions (∼10%). Hypnotics did not affect genioglossus responsiveness (high QoE). Conclusions: Further research testing or clinical use of hypnotics as OSA alternative treatments should be discouraged, unless in the presence of comorbid insomnia or as part of combination therapy in individuals with very low arousal threshold.
引用
- Messineo L, Sands SA, Labarca G, et al. Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis. Am J Respir Crit Care Med. 2024. PMID: 39042859. doi:10.1164/rccm.202403-0501OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。